中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2012, Vol. 47 Issue (14) :1101-1104    DOI:
���� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
�˲�����ҩ��ѧ�о���չ
��Ч�ͣ��Ŵ�������ҫ��*
�㽭��ҽҩ��ѧҩѧԺ������ 310053)

Download: PDF (0KB)   HTML (1KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� �����˲����յ�ҩ��ѧ�о���չ������ �Թ������о�����Ϊ���������������Ͻ��з������ܽᡣ��� �ܽ����˲�����ҩ��ѧ�ķ�չ�������ع��ɷ������˲����յ�ҩ��ѧ��������Ӱ�����ء��˲�����ҩ��ѧ�о��·�������˼·������ �����¼������·����ķ�չ��Ӧ�ã��˲����յ�ҩ��ѧ��ע��“Ũ��-ʱ��-ЧӦ”���ϵ�PK-PD�о�����Ӧ�ӵ�һ�ɷֵ�ҩ��ѧ���ЧӦ�ɷֵ�����ҩ��ѧ����չ��
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
����
�Ŵ���
��ҫ��*
�ؼ����� �˲�����   ҩ��ѧ   ��ҩ����     
Abstract��
Keywords��   
�ո�����: 2011-05-25;
��������:

�㽭ʡ��Ȼ��ѧ�����ص���Ŀ��Z2091224��

���߼��: ��Ч�ͣ�Ů����ʿ �о�������ҩ��Դ���������� ��ͨѶ���ߣ���ҫ�����У����� �о�������ҩ��Դ���������� Tel����0571��86633118 E-mail��xiongyaokang@tom.com
���ñ���:   
��Ч��, �Ŵ���, ��ҫ��* .�˲�����ҩ��ѧ�о���չ[J]  �й�ҩѧ��־, 2012,V47(14): 1101-1104
LI Xiao-Xian, Zhang-Chun-Chun, Xiong-Yao-Kang-* .[J]  Chinese Pharmaceutical Journal, 2012,V47(14): 1101-1104
��
[1] ZHANG G�� LIU A�� ZHOU Y�� et al. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia [J]. J Ethnopharmacol�� 2008�� 115(3)��441-448.
[2] YU X T��WANG S P. Clinical observation on treatment for postoperative gastric cancer by ginsenoside Rg3 combined with chemotherapy [J]. Chin J Cancer Prev Treat(�л�����������־)�� 2010�� 17(10)��779-781.
[3] ZHANG Z�� JIANG B�� ZHENG X�� et al. Immune enhancing effects of Rg3 on peripheral lymphocytes in vitro in cancer patients treated with radiotherapy [J]. Chin Pharm J (�й�ҩѧ��־)�� 2004�� 39(4)��261-264.
[4] SUI D Y�� YU X F�� QU S C�� et al. Effects of Panax quinquefolium 20S-2protopanaxdiol saponins on experimental ventricular remodeling in rat [J]. Chin Pharm J (�й�ҩѧ��־)�� 2007�� 42(2)��108-112.
[5] LEE Y�� JIN Y�� LIM W�� et al. A ginsenoside-Rh1�� a component of ginseng saponin�� activates estrogen receptor in human breast carcinoma MCF-7 cells [J]. J Steroid Biochem�� 2003�� 84(4)��463-468.
[6] WILLIAM C S�� CHUNG W S�� SALLY K W�� et al. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats [J]. Eur J Pharmacol�� 2006�� 550��1-3����173-179.
[7] KIM S E�� LEE Y H�� PARK H J�� et al. Ginsenoside-Rs4�� a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells European [J]. Eur J Cancer�� 1999�� 35(3)��507-511.
[8] LI H�� SUN J G�� XIE H T�� et al. Study on absorption mechanism of ginsenoside Rg1 using rat everted gut sac [J]. Chin J Clin Pharmacol Ther (�й��ٴ�ҩ��ѧ������ѧ)�� 2004�� 9(5)��510-513.
[9] FENG L�� HU C J�� YU L Y�� et al. Pharmacokinetics of ginsenoside Rg1 and its metabolites in rats [J]. Acta Pharm Sin (ҩѧѧ��)�� 2010�� 45(5)��636-640.
[10] LEE J�� LEE E�� KIM D�� et al. Studies on absorption�� distribution and metabolism of ginseng in humans after oral administration [J]. J Ethnopharmacol�� 2009�� 122(1)��143-148.
[11] YANG X W�� GUI F J�� TIAN J M�� et al. Pharmacokinetics of ginsenoside-Rg2 in rats [J]. Chin Pharmacol Bull(�й�ҩ��ѧͨ��)�� 2009�� 25(7)��967-970.
[12] GUI F J�� YANG X W�� LI L Y�� et al. Simultaneous enantiomer determination of 20 (R)- and 20 (S)-ginsenoside-Rg2 in rat plasma after intravenous administration using HPLC method [J]. J Chromatography B�� 2007�� 850(1-2)��1-6.
[13] HUANG Y�� LIU J H. Pharmacokinetic study of ginsenoside 20(S)-Rg3 in rats by HPLC- ELSD [J]. J Pr Med Theory (ʵ��ҽ����־)�� 2005�� 12(9)��2564-2566.
[14] CAI Z�� QIAN T�� WONG R�� et al. Liquid chromatography-electrospray ionization mass spectrometry for metabolism and pharmacokinetic studies of ginsenoside Rg3 [J]. Anal Chim Acta�� 2003�� 492(1-2)��283-293.
[15] LIU L�� HUANG J�� HU X�� et al. Simultaneous determination of ginsenoside (G-Re�� G-Rg1�� G-Rg2�� G-F1�� G-Rh1) and protopanaxatriol in human plasma and urine by LC-MS/MS and its application in a pharmacokinetics study of G-Re in volunteers [J]. J Chromatography B�� 2011�� 22(15)��2011-2017.
[16] JOO K�� LEE H J�� JEON H Y�� et al. Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method [J]. J Pharmaceut Biomed�� 2010�� 51(1-2)��278-283.
[17] QIAN T�� JIANG Z H�� CAI Z. High-performance liquid chromatography coupled with tandem mass spectrometry applied for metabolic study of ginsenoside Rb1 on rat [J]. Anal Biochem�� 2006�� 352(1)��87-96.
[18] GU Y�� WANG G J�� SUN J G. Pharmacokinetic characterization of ginsenoside Rh2�� an anticancer nutrient from ginseng�� in rats and dogs [J]. Food Chem Toxicol�� 2009�� 47(9)��2257-2268.
[19] YANG L�� DENG Y�� XU S�� et al. In vivo pharmacokinetic and metabolism studies of ginsenoside Rd [J]. J Chromatography B�� 2007�� 854(1-2)��77-84.
[20] WANG W�� WANG G J�� XIE H T�� et al. Determination of ginsenoside Rd in dog plasma by liquid chromatography-mass spectrometry after solid-phase extraction and its application in dog pharmacokinetics studies [J]. J Chromatography B�� 2007�� 852(1-2)��8-14.
[21] JIANG J�� LI S�� GONG P L�� et al. Pharmacokinetics of Shengmaiyin oral solution after a single dose in human [J]. Acta Med Univ Sci Technol Huazhong(���пƼ���ѧѧ��ҽѧ��)�� 2007�� 36(2)��272-274.
[22] LIN L�� ZU F Y�� ZHANG W W�� et al. Effects of compound compatibility on absorption in vitro of ginsenoside saponins[J]. Chin J Mod Drug Appl (�й��ִ�ҩ��Ӧ��)�� 2010�� 4(13)��150-152.
[23] LUO D F�� YE J T�� ZHANGY S�� et al. Studies on drug release in vitro and absorption in rat in vivo of ginsenoside Rd solid lipid nanoparticles [J]. Chin Pharmacol Bull(�й�ҩ��ѧͨ��)�� 2009�� 25(7)��923-926.
[24] GU Y�� WANG G J�� SUN J G�� et al. Pharmacokinetic study of ginsenoside 20(R)-Rh2 in Beagle dogs by LC-ESI-MS [J]. Chin J Clin Pharmacol Ther (�й��ٴ�ҩ��ѧ������ѧ)�� 2006��11��3����159-163.
[25] DENG Y H�� ZENG X�� FENG Y�� et al. Pharmacokinetics and tolerance of single dose intravenous drip of ginsenoside-Rd injection in Chinese healthy volunteers [J]. Chin J Clin Pharmacol (�й��ٴ�ҩ��ѧ��־)�� 2009�� 25(2)��116-120.
[26] PENG Y�� WANG S J�� PAN W S�� et al. Pharmacokinetics of ginsenoside Re in rat [J]. J Shenyang Pharm Univ (����ҩ�ƴ�ѧѧ��)�� 2006�� 23(4)��197-200.
[27] REN H C�� SUN J G�� WANG G J�� et al. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS��Application of pharmacokinetic study in rats [J]. J Pharm Biomed�� 2008�� 48(5)��1476-1480.
[28] ZHOU W�� SHI R B�� SUN J N�� et al. Pharmacokinetics of effective fractions of Qingnaoxuanqiao Formula in different rat models [J]. J Beijing Unit Tradit Chin Med (������ҽҩ��ѧѧ��)�� 2008�� 31(4)��265-268.
[29] LI X Y�� HAO H P�� WANG G J�� et al. Integrated pharmacokinetic study of multiple effective components contained in total panax notoginsenosides[J]. Chin J Nat Med (�й���Ȼҩ��)�� 2008�� 6(5)��377-381.
[30] SONG M�� ZHANG S�� XU X�� et al. Simultaneous determination of three Panax notoginseng saponins at sub-nanograms by LC-MS/MS in dog plasma for pharmacokinetics of compound Danshen tablets [J]. J Chromatography B�� 2010��878(32)��3331-3337.
[31] WANG Z����MA X�� CHEN X�� et al. Current methods and advances in microbial metabolom ics [J]. Prog Chen (��ѧ��չ)�� 2010�� 22(1)��163-172.
[1] ������;����;�;������;л����;����.��ҩ�նԸʲ��ἰ�ʲݴ����������ҩ��ѧ��Ӱ��[J]. �й�ҩѧ��־, 2012,47(8): 599-602
[2] ��С�� ��ӱ ��½�� κӱ�� ��ǿ ���.�������������������Ʊ�����������ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(7): 524-528
[3] ��Ң ̷־�� ��ҽ�� ������ ��ΰ �ܺ��.Һ��ɫ�״������׷��ⶨ����Ѫ��ά������Ũ�ȼ������Ч�������о�[J]. �й�ҩѧ��־, 2012,47(7): 546-550
[4] ��ƽ ֣�� ����ϼ Ԭ��Ӣ ���� Ǯ���� �㵤 ������ �»� .�������徲����עͷ����ͪ�Ƶ�ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(4): 291-295
[5] ������ ����Ƽ ���ж� ʩТ�� ������.����Ī˾�����������ڵ������Ч������[J]. �й�ҩѧ��־, 2012,47(4): 296-302
[6] ���� ��ѩ�� ��� ���� ���� ���ٹ� .ע���������������׽ṹ֬������ϵͳ���Ʊ���������ҩ������ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(4): 287-290
[7] ���� ���� ������ ��־�� ������ .���Ҷ������εĶ������֬�������ҹ������������ڵ�ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(3): 223-
[8] ¦�� ������ ���� ���� ���� ���� ������ ������.��ͬ����������Ȼ���˨������ҩ��ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(3): 209-
[9] ������ ����÷ ���� ������ ���ҷ� ʦ�پ�.ע����ͷ����̹�������й����������ڵ�ҩ��ѧ[J]. �й�ҩѧ��־, 2012,47(2): 132-135
[10] ��ӱ ����ѫ ���� ����Ⱥ.����ڷ����컨��-1��������Ѫ�ɷּ�ҩ��ѧ[J]. �й�ҩѧ��־, 2012,47(2): 136-140
[11] ������ ����ΰ ������.���ᴨܺັ���pH������ԭλ��������ѪҺ���Բ�ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(2): 119-121
[12] ���޽������������Ƽ����ϲƽ���ų���������*.�����濵�������Ը����˴������ڵ�ҩ��ѧ�����о�[J]. �й�ҩѧ��־, 2012,47(15): 1233-1236
[13] �ž������䣬������*������.�������׷��о���������������Ҫ��л���ҩ��ѧ[J]. �й�ҩѧ��־, 2012,47(15): 1237-1241
[14] ���Σ��Ķ��ǣ�����������ɽ����ƽ��Ф�£��Զ��飬��࣬����.����������ͷ��������й����������Ⱥ�е�ҩ��ѧ[J]. �й�ҩѧ��־, 2012,47(14): 1134-1138
[15] ���磬���޷����Իԣ��������������.BeagleȮ���赥�����������ᰱ�ȵ�ƽ/��ɳ̹��Ƭ����Ч�ɷְ��ȵ�ƽ����ɳ̹�����л����EXP3174��ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(14): 1139-1142
Copyright 2010 by �й�ҩѧ��־